Sign in
8-K

Current Report

Celldex Therapeutics, Inc. Filed Acc 0001104659-08-016816

Acquisition or sale completed · Delisting notice · Shareholder rights changed · Change in control · Executive or director change · Other events

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 3.03 Material modification to rights of security holders
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading a08-7923_18k.htm…